{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T22:48:40Z","timestamp":1789771720324,"version":"4.0.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatologie"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s00105-025-05511-2","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T11:36:51Z","timestamp":1746704211000},"page":"365-370","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Stellenwert der Chirurgie des malignen Melanoms im Kontext aktueller adjuvanter und neoadjuvanter Therapiekonzepte","Value of surgery for malignant melanoma in the context of current adjuvant and neoadjuvant treatment concepts"],"prefix":"10.1007","volume":"76","author":[{"given":"Mareike","family":"Alter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Gutzmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,8]]},"reference":[{"issue":"1","key":"5511_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/JCO.1996.14.1.1","volume":"14","author":"CM Balch","year":"1996","unstructured":"Balch\u00a0CM, Buzaid\u00a0AC (1996) Finally, a\u00a0successful adjuvant therapy for high-risk melanoma. J\u00a0Clin Oncol 14(1):1\u20133. https:\/\/doi.org\/10.1200\/JCO.1996.14.1.1","journal-title":"J Clin Oncol"},{"issue":"3","key":"5511_CR2","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1097\/00000658-199309000-00005","volume":"218","author":"CM Balch","year":"1993","unstructured":"Balch\u00a0CM, Urist\u00a0MM, Karakousis\u00a0CP, Smith\u00a0TJ, Temple\u00a0WJ, Drzewiecki\u00a0K, Jewell\u00a0WR, Bartolucci\u00a0AA, Mihm\u00a0MC Jr, Barnhill\u00a0R et\u00a0al (1993) Efficacy of 2\u2011cm surgical margins for intermediate-thickness melanomas (1 to 4\u202fmm). Results of a\u00a0multi-institutional randomized surgical trial. Ann Surg 218(3):262\u2013267. https:\/\/doi.org\/10.1097\/00000658-199309000-00005","journal-title":"Ann Surg"},{"issue":"3","key":"5511_CR3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/00000658-199609000-00002","volume":"224","author":"CM Balch","year":"1996","unstructured":"Balch\u00a0CM, Soong\u00a0SJ, Bartolucci\u00a0AA, Urist\u00a0MM, Karakousis\u00a0CP, Smith\u00a0TJ, Temple\u00a0WJ, Ross\u00a0MI, Jewell\u00a0WR, Mihm\u00a0MC, Barnhill\u00a0RL, Wanebo\u00a0HJ (1996) Efficacy of an elective regional lymph node dissection of 1\u00a0to 4\u202fmm thick melanomas for patients 60\u00a0years of age and younger. Ann Surg 224(3):255\u2013263. https:\/\/doi.org\/10.1097\/00000658-199609000-00002","journal-title":"Ann Surg"},{"issue":"2","key":"5511_CR4","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10434-000-0087-9","volume":"7","author":"CM Balch","year":"2000","unstructured":"Balch\u00a0CM, Soong\u00a0S, Ross\u00a0MI, Urist\u00a0MM, Karakousis\u00a0CP, Temple\u00a0WJ, Mihm\u00a0MC, Barnhill\u00a0RL, Jewell\u00a0WR, Wanebo\u00a0HJ, Harrison\u00a0R (2000) Long-term results of a\u00a0multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0\u202fmm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol 7(2):87\u201397. https:\/\/doi.org\/10.1007\/s10434-000-0087-9","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"5511_CR5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10434-001-0101-x","volume":"8","author":"CM Balch","year":"2001","unstructured":"Balch\u00a0CM, Soong\u00a0SJ, Smith\u00a0T, Ross\u00a0MI, Urist\u00a0MM, Karakousis\u00a0CP, Temple\u00a0WJ, Mihm\u00a0MC, Barnhill\u00a0RL, Jewell\u00a0WR, Wanebo\u00a0HJ, Desmond\u00a0R (2001) Investigators from the Intergroup Melanoma Surgical Trial. Long-term results of a\u00a0prospective surgical trial comparing 2\u202fcm vs. 4\u202fcm excision margins for 740 patients with 1\u20134\u202fmm melanomas. Ann Surg Oncol 8(2):101\u2013108. https:\/\/doi.org\/10.1007\/s10434-001-0101-x","journal-title":"Ann Surg Oncol"},{"issue":"18","key":"5511_CR6","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1056\/NEJMoa2402604","volume":"391","author":"CU Blank","year":"2024","unstructured":"Blank\u00a0CU, Lucas\u00a0MW, Scolyer\u00a0RA, van de Wiel\u00a0BA, Menzies\u00a0AM, Lopez-Yurda\u00a0M, Hoeijmakers\u00a0LL, Saw\u00a0RPM, Lijnsvelt\u00a0JM, Maher\u00a0NG, Pulleman\u00a0SM, Gonzalez\u00a0M, Torres Acosta\u00a0A, van Houdt\u00a0WJ, Lo\u00a0SN, Kuijpers\u00a0AMJ, Spillane\u00a0A, Klop\u00a0WMC, Pennington\u00a0TE, Zuur\u00a0CL, Shannon\u00a0KF, Seinstra\u00a0BA, Rawson\u00a0RV, Haanen\u00a0JBAG, Ch\u2019ng\u00a0S, Naipal\u00a0KAT, Stretch\u00a0J, van Thienen\u00a0JV, Rtshiladze\u00a0MA, Wilgenhof\u00a0S, Kapoor\u00a0R, Meerveld-Eggink\u00a0A, Grijpink-Ongering\u00a0LG, van Akkooi\u00a0ACJ, Reijers\u00a0ILM, Gyorki\u00a0DE, Gr\u00fcnhagen\u00a0DJ, Speetjens\u00a0FM, Vliek\u00a0SB, Placzke\u00a0J, Spain\u00a0L, Stassen\u00a0RC, Amini-Adle\u00a0M, Lebb\u00e9\u00a0C, Faries\u00a0MB, Robert\u00a0C, Ascierto\u00a0PA, van Rijn\u00a0R, van den Berkmortel\u00a0FWPJ, Piersma\u00a0D, van der Westhuizen\u00a0A, Vreugdenhil\u00a0G, Aarts\u00a0MJB, Stevense-den Boer\u00a0MAM, Atkinson\u00a0V, Khattak\u00a0M, Andrews\u00a0MC, van den Eertwegh\u00a0AJM, Boers-Sonderen\u00a0MJ, Hospers\u00a0GAP, Carlino\u00a0MS, de Groot\u00a0JB, Kapiteijn\u00a0E, Suijkerbuijk\u00a0KPM, Rutkowski\u00a0P, Sandhu\u00a0S, van der Veldt\u00a0AAM, Long\u00a0GV (2024) Neoadjuvant nivolumab and ipilimumab in resectable stage\u00a0III melanoma. N\u00a0Engl J Med 391(18):1696\u20131708. https:\/\/doi.org\/10.1056\/NEJMoa2402604","journal-title":"N Engl J Med"},{"issue":"4","key":"5511_CR7","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/(SICI)1098-2388(199806)14:4<272::AID-SSU2>3.0.CO;2-#","volume":"14","author":"N Cascinelli","year":"1998","unstructured":"Cascinelli\u00a0N (1998) Margin of resection in the management of primary melanoma. Semin Surg Oncol 14(4):272\u2013275","journal-title":"Semin Surg Oncol"},{"issue":"9105","key":"5511_CR8","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/s0140-6736(97)08260-3","volume":"351","author":"N Cascinelli","year":"1998","unstructured":"Cascinelli\u00a0N, Morabito\u00a0A, Santinami\u00a0M, MacKie\u00a0RM, Belli\u00a0F (1998) Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a\u00a0randomised trial. Lancet 351(9105):793\u2013796. https:\/\/doi.org\/10.1016\/s0140-6736(97)08260-3","journal-title":"Lancet"},{"issue":"7","key":"5511_CR9","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1002\/1097-0142(20001001)89:7<1495::AID-CNCR12>3.0.CO;2-D","volume":"89","author":"G Cohn-Cedermark","year":"2000","unstructured":"Cohn-Cedermark\u00a0G, Rutqvist\u00a0LE, Andersson\u00a0R, Breivald\u00a0M, Ingvar\u00a0C, Johansson\u00a0H, J\u00f6nsson\u00a0PE, Krysander\u00a0L, Lindholm\u00a0C, Ringborg\u00a0U (2000) Long term results of a\u00a0randomized study by the Swedish Melanoma Study Group on 2\u2011cm versus 5\u2011cm resection margins for patients with cutaneous melanoma with a\u00a0tumor thickness of 0.8\u20132.0\u202fmm. Cancer 89(7):1495\u20131501","journal-title":"Cancer"},{"issue":"23","key":"5511_CR10","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","volume":"376","author":"MB Faries","year":"2017","unstructured":"Faries\u00a0MB, Thompson\u00a0JF, Cochran\u00a0AJ, Andtbacka\u00a0RH, Mozzillo\u00a0N, Zager\u00a0JS, Jahkola\u00a0T, Bowles\u00a0TL, Testori\u00a0A, Beitsch\u00a0PD, Hoekstra\u00a0HJ, Moncrieff\u00a0M, Ingvar\u00a0C, Wouters\u00a0MWJM, Sabel\u00a0MS, Levine\u00a0EA, Agnese\u00a0D, Henderson\u00a0M, Dummer\u00a0R, Rossi\u00a0CR, Neves\u00a0RI, Trocha\u00a0SD, Wright\u00a0F, Byrd\u00a0DR, Matter\u00a0M, Hsueh\u00a0E, MacKenzie-Ross\u00a0A, Johnson\u00a0DB, Terheyden\u00a0P, Berger\u00a0AC, Huston\u00a0TL, Wayne\u00a0JD, Smithers\u00a0BM, Neuman\u00a0HB, Schneebaum\u00a0S, Gershenwald\u00a0JE, Ariyan\u00a0CE, Desai\u00a0DC, Jacobs\u00a0L, McMasters\u00a0KM, Gesierich\u00a0A, Hersey\u00a0P, Bines\u00a0SD, Kane\u00a0JM, Barth\u00a0RJ, McKinnon\u00a0G, Farma\u00a0JM, Schultz\u00a0E, Vidal-Sicart\u00a0S, Hoefer\u00a0RA, Lewis\u00a0JM, Scheri\u00a0R, Kelley\u00a0MC, Nieweg\u00a0OE, Noyes\u00a0RD, Hoon\u00a0DSB, Wang\u00a0HJ, Elashoff\u00a0DA, Elashoff\u00a0RM (2017) Completion dissection or observation for sentinel-node metastasis in melanoma. N\u00a0Engl J Med 376(23):2211\u20132222. https:\/\/doi.org\/10.1056\/NEJMoa1613210","journal-title":"N Engl J Med"},{"issue":"3","key":"5511_CR11","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1200\/JCO.1999.17.3.976","volume":"17","author":"JE Gershenwald","year":"1999","unstructured":"Gershenwald\u00a0JE, Thompson\u00a0W, Mansfield\u00a0PF, Lee\u00a0JE, Colome\u00a0MI, Tseng\u00a0CH, Lee\u00a0JJ, Balch\u00a0CM, Reintgen\u00a0DS, Ross\u00a0MI (1999) Multi-institutional melanoma lymphatic mapping experience: The prognostic value of sentinel lymph node status in 612 stage\u00a0I or II melanoma patients. J\u00a0Clin Oncol 17(3):976\u2013983. https:\/\/doi.org\/10.1200\/JCO.1999.17.3.976","journal-title":"J Clin Oncol"},{"issue":"9803","key":"5511_CR12","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1016\/S0140-6736(11)61546-8","volume":"378","author":"P Gillgren","year":"2011","unstructured":"Gillgren\u00a0P, Drzewiecki\u00a0KT, Niin\u00a0M, Gullestad\u00a0HP, Hellborg\u00a0H, M\u00e5nsson-Brahme\u00a0E, Ingvar\u00a0C, Ringborg\u00a0U (2011) 2\u2011cm versus 4\u2011cm surgical excision margins for primary cutaneous melanoma thicker than 2\u202fmm: A\u00a0randomised, multicentre trial. Lancet 378(9803):1635\u20131642. https:\/\/doi.org\/10.1016\/S0140-6736(11)61546-8 (Epub 2011 Oct 23; Erratum in: Lancet 378(9803):1626; PMID: 22027547)","journal-title":"Lancet"},{"issue":"6","key":"5511_CR13","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1111\/j.1365-2133.2005.06941.x","volume":"153","author":"R Gutzmer","year":"2005","unstructured":"Gutzmer\u00a0R, Al Ghazal\u00a0M, Geerlings\u00a0H, Kapp\u00a0A (2005) Sentinel node biopsy in melanoma delays recurrence but does not change melanoma-related survival: A\u00a0retrospective analysis of 673 patients. Br J Dermatol 153(6):1137\u20131141. https:\/\/doi.org\/10.1111\/j.1365-2133.2005.06941.x","journal-title":"Br J Dermatol"},{"issue":"3","key":"5511_CR14","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/j.1610-0387.2007.06569.x","volume":"6","author":"R Gutzmer","year":"2008","unstructured":"Gutzmer\u00a0R, Satzger\u00a0I, Thoms\u00a0KM, V\u00f6lker\u00a0B, Mitteldorf\u00a0C, Kapp\u00a0A, Bertsch\u00a0HP, Kretschmer\u00a0L (2008) Sentinel lymph node status is the most important prognostic factor for thick (> or\u00a0= 4\u202fmm) melanomas. J\u00a0Dtsch Dermatol Ges 6(3):198\u2013203. https:\/\/doi.org\/10.1111\/j.1610-0387.2007.06569.x","journal-title":"J Dtsch Dermatol Ges"},{"issue":"2","key":"5511_CR15","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/S1470-2045(15)00482-9","volume":"17","author":"AJ Hayes","year":"2016","unstructured":"Hayes\u00a0AJ, Maynard\u00a0L, Coombes\u00a0G, Newton-Bishop\u00a0J, Timmons\u00a0M, Cook\u00a0M, Theaker\u00a0J, Bliss\u00a0JM, Thomas\u00a0JM, UK Melanoma Study Group, British Association of Plastic, Reconstructive and Aesthetic Surgeons, and the Scottish Cancer Therapy Network (2016) Wide versus narrow excision margins for high-risk, primary cutaneous melanomas: Long-term follow-up of survival in a\u00a0randomised trial. Lancet Oncol 17(2):184\u2013192. https:\/\/doi.org\/10.1016\/S1470-2045(15)00482-9","journal-title":"Lancet Oncol"},{"issue":"5","key":"5511_CR16","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/BF02305762","volume":"3","author":"CP Karakousis","year":"1996","unstructured":"Karakousis\u00a0CP, Balch\u00a0CM, Urist\u00a0MM, Ross\u00a0MM, Smith\u00a0TJ, Bartolucci\u00a0AA (1996) Local recurrence in malignant melanoma: Long-term results of the multiinstitutional randomized surgical trial. Ann Surg Oncol 3(5):446\u2013452. https:\/\/doi.org\/10.1007\/BF02305762","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"5511_CR17","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/cncr.11272","volume":"97","author":"D Khayat","year":"2003","unstructured":"Khayat\u00a0D, Rixe\u00a0O, Martin\u00a0G, Soubrane\u00a0C, Banzet\u00a0M, Bazex\u00a0JA, Lauret\u00a0P, V\u00e9rola\u00a0O, Auclerc\u00a0G, Harper\u00a0P, Banzet\u00a0P, French Group of Research on Malignant Melanoma (2003) Surgical margins in cutaneous melanoma (2\u202fcm versus 5\u202fcm for lesions measuring less than 2.1-mm thick). Cancer 97(8):1941\u20131946. https:\/\/doi.org\/10.1002\/cncr.11272","journal-title":"Cancer"},{"issue":"1","key":"5511_CR18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/CMR.0b013e3282f2017d","volume":"18","author":"L Kretschmer","year":"2008","unstructured":"Kretschmer\u00a0L, Thoms\u00a0KM, Peeters\u00a0S, Haenssle\u00a0H, Bertsch\u00a0HP, Emmert\u00a0S (2008) Postoperative morbidity of lymph node excision for cutaneous melanoma-sentinel lymphonodectomy versus complete regional lymph node dissection. Melanoma Res 18(1):16\u201321. https:\/\/doi.org\/10.1097\/CMR.0b013e3282f2017d","journal-title":"Melanoma Res"},{"issue":"6","key":"5511_CR19","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S1470-2045(16)00141-8","volume":"17","author":"U Leiter","year":"2016","unstructured":"Leiter\u00a0U, Stadler\u00a0R, Mauch\u00a0C, Hohenberger\u00a0W, Brockmeyer\u00a0N, Berking\u00a0C, Sunderk\u00f6tter\u00a0C, Kaatz\u00a0M, Schulte\u00a0KW, Lehmann\u00a0P, Vogt\u00a0T, Ulrich\u00a0J, Herbst\u00a0R, Gehring\u00a0W, Simon\u00a0JC, Keim\u00a0U, Martus\u00a0P, Garbe\u00a0C, German Dermatologic Cooperative Oncology Group (DeCOG) (2016) Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): A\u00a0multicentre, randomised, phase\u00a03\u00a0trial. Lancet Oncol 17(6):757\u2013767. https:\/\/doi.org\/10.1016\/S1470-2045(16)00141-8","journal-title":"Lancet Oncol"},{"issue":"32","key":"5511_CR20","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.1200\/JCO.18.02306","volume":"37","author":"U Leiter","year":"2019","unstructured":"Leiter\u00a0U, Stadler\u00a0R, Mauch\u00a0C, Hohenberger\u00a0W, Brockmeyer\u00a0NH, Berking\u00a0C, Sunderk\u00f6tter\u00a0C, Kaatz\u00a0M, Schatton\u00a0K, Lehmann\u00a0P, Vogt\u00a0T, Ulrich\u00a0J, Herbst\u00a0R, Gehring\u00a0W, Simon\u00a0JC, Keim\u00a0U, Verver\u00a0D, Martus\u00a0P, Garbe\u00a0C, German Dermatologic Cooperative Oncology Group (2019) Final analysis of DeCOG-SLT trial: No survival benefit for complete lymph node dissection in patients with melanoma with positive sentinel node. J\u00a0Clin Oncol 37(32):3000\u20133008. https:\/\/doi.org\/10.1200\/JCO.18.02306","journal-title":"J Clin Oncol"},{"issue":"10","key":"5511_CR21","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1200\/JCO.2015.63.3776","volume":"34","author":"KM McMasters","year":"2016","unstructured":"McMasters\u00a0KM, Egger\u00a0ME, Edwards\u00a0MJ, Ross\u00a0MI, Reintgen\u00a0DS, Noyes\u00a0RD, Martin\u00a0RC 2nd, Goydos\u00a0JS, Beitsch\u00a0PD, Urist\u00a0MM, Ariyan\u00a0S, Sussman\u00a0JJ, Davidson\u00a0BS, Gershenwald\u00a0JE, Hagendoorn\u00a0LJ, Stromberg\u00a0AJ, Scoggins\u00a0CR (2016) Final results of the sunbelt melanoma trial: A\u00a0multi-institutional prospective randomized phase\u00a0III study evaluating the role of adjuvant high-dose interferon alfa-2b and completion lymph node dissection for patients staged by sentinel lymph node biopsy. J\u00a0Clin Oncol 34(10):1079\u20131086. https:\/\/doi.org\/10.1200\/JCO.2015.63.3776","journal-title":"J Clin Oncol"},{"issue":"9","key":"5511_CR22","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1245\/s10434-018-6470-1","volume":"25","author":"MD Moncrieff","year":"2018","unstructured":"Moncrieff\u00a0MD, Gyorki\u00a0D, Saw\u00a0R, Spillane\u00a0AJ, Thompson\u00a0JF, Peach\u00a0H, Oudit\u00a0D, Geh\u00a0J, Dziewulski\u00a0P, Wilson\u00a0E, Matteucci\u00a0P, Pritchard-Jones\u00a0R, Olofsson Bagge\u00a0R, Wright\u00a0FC, Crampton\u00a0N, Cassell\u00a0O, Jallali\u00a0N, Berger\u00a0A, Kelly\u00a0J, Hamilton\u00a0S, Durrani\u00a0A, Lo\u00a0S, Paton\u00a0E, Henderson\u00a0MA (2018) 1 versus 2\u2011cm excision margins for pT2\u2013pT4 primary cutaneous melanoma (MelMarT): A\u00a0feasibility study. Ann Surg Oncol 25(9):2541\u20132549. https:\/\/doi.org\/10.1245\/s10434-018-6470-1","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"5511_CR23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/00000658-199008000-00001","volume":"212","author":"DL Morton","year":"1990","unstructured":"Morton\u00a0DL (1990) Current management of malignant melanoma. Ann Surg 212(2):123\u2013124. https:\/\/doi.org\/10.1097\/00000658-199008000-00001","journal-title":"Ann Surg"},{"issue":"4","key":"5511_CR24","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1001\/archsurg.1992.01420040034005","volume":"127","author":"DL Morton","year":"1992","unstructured":"Morton\u00a0DL, Wen\u00a0DR, Wong\u00a0JH, Economou\u00a0JS, Cagle\u00a0LA, Storm\u00a0FK, Foshag\u00a0LJ, Cochran\u00a0AJ (1992) Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127(4):392\u2013399. https:\/\/doi.org\/10.1001\/archsurg.1992.01420040034005","journal-title":"Arch Surg"},{"issue":"13","key":"5511_CR25","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1056\/NEJMoa060992","volume":"355","author":"DL Morton","year":"2006","unstructured":"Morton\u00a0DL, Thompson\u00a0JF, Cochran\u00a0AJ, Mozzillo\u00a0N, Elashoff\u00a0R, Essner\u00a0R, Nieweg\u00a0OE, Roses\u00a0DF, Hoekstra\u00a0HJ, Karakousis\u00a0CP, Reintgen\u00a0DS, Coventry\u00a0BJ, Glass\u00a0EC, Wang\u00a0HJ, MSLT Group (2006) Sentinel-node biopsy or nodal observation in melanoma. N\u00a0Engl J Med 355(13):1307\u20131317. https:\/\/doi.org\/10.1056\/NEJMoa060992 (Erratum in: N Engl J Med 355(18):1944)","journal-title":"N Engl J Med"},{"issue":"9","key":"5511_CR26","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1001\/jamasurg.2022.2055","volume":"157","author":"JS Crystal","year":"2022","unstructured":"Multicenter Selective Lymphadenectomy Trials Study Group, Crystal\u00a0JS, Thompson\u00a0JF, Hyngstrom\u00a0J, Carac\u00f2\u00a0C, Zager\u00a0JS, Jahkola\u00a0T, Bowles\u00a0TL, Pennacchioli\u00a0E, Beitsch\u00a0PD, Hoekstra\u00a0HJ, Moncrieff\u00a0M, Ingvar\u00a0C, van Akkooi\u00a0A, Sabel\u00a0MS, Levine\u00a0EA, Agnese\u00a0D, Henderson\u00a0M, Dummer\u00a0R, Neves\u00a0RI, Rossi\u00a0CR, Kane\u00a0JM 3rd, Trocha\u00a0S, Wright\u00a0F, Byrd\u00a0DR, Matter\u00a0M, Hsueh\u00a0EC, MacKenzie-Ross\u00a0A, Kelley\u00a0M, Terheyden\u00a0P, Huston\u00a0TL, Wayne\u00a0JD, Neuman\u00a0H, Smithers\u00a0BM, Ariyan\u00a0CE, Desai\u00a0D, Gershenwald\u00a0JE, Schneebaum\u00a0S, Gesierich\u00a0A, Jacobs\u00a0LK, Lewis\u00a0JM, McMasters\u00a0KM, O\u2019Donoghue\u00a0C, van der Westhuizen\u00a0A, Sardi\u00a0A, Barth\u00a0R, Barone\u00a0R, McKinnon\u00a0JG, Slingluff\u00a0CL, Farma\u00a0JM, Schultz\u00a0E, Scheri\u00a0RP, Vidal-Sicart\u00a0S, Molina\u00a0M, Testori\u00a0AAE, Foshag\u00a0LJ, Van Kreuningen\u00a0L, Wang\u00a0HJ, Sim\u00a0MS, Scolyer\u00a0RA, Elashoff\u00a0DE, Cochran\u00a0AJ, Faries\u00a0MB (2022) Therapeutic value of sentinel lymph node biopsy in patients with melanoma: A\u00a0randomized clinical trial. JAMA Surg 157(9):835\u2013842. https:\/\/doi.org\/10.1001\/jamasurg.2022.2055 (Erratum in: JAMA Surg 157(9):859)","journal-title":"JAMA Surg"},{"issue":"5","key":"5511_CR27","doi-asserted-by":"publisher","first-page":"895","DOI":"10.3390\/cancers16050895","volume":"16","author":"SE Orme","year":"2024","unstructured":"Orme\u00a0SE, Moncrieff\u00a0MD (2024) A\u00a0review of contemporary guidelines and evidence for wide local excision in primary cutaneous melanoma management. Cancers (Basel) 16(5):895. https:\/\/doi.org\/10.3390\/cancers16050895","journal-title":"Cancers (Basel)"},{"issue":"9","key":"5511_CR28","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1056\/NEJMoa2211437","volume":"388","author":"SP Patel","year":"2023","unstructured":"Patel\u00a0SP, Othus\u00a0M, Chen\u00a0Y, Wright\u00a0GP Jr, Yost\u00a0KJ, Hyngstrom\u00a0JR, Hu-Lieskovan\u00a0S, Lao\u00a0CD, Fecher\u00a0LA, Truong\u00a0TG, Eisenstein\u00a0JL, Chandra\u00a0S, Sosman\u00a0JA, Kendra\u00a0KL, Wu\u00a0RC, Devoe\u00a0CE, Deutsch\u00a0GB, Hegde\u00a0A, Khalil\u00a0M, Mangla\u00a0A, Reese\u00a0AM, Ross\u00a0MI, Poklepovic\u00a0AS, Phan\u00a0GQ, Onitilo\u00a0AA, Yasar\u00a0DG, Powers\u00a0BC, Doolittle\u00a0GC, In\u00a0GK, Kokot\u00a0N, Gibney\u00a0GT, Atkins\u00a0MB, Shaheen\u00a0M, Warneke\u00a0JA, Ikeguchi\u00a0A, Najera\u00a0JE, Chmielowski\u00a0B, Crompton\u00a0JG, Floyd\u00a0JD, Hsueh\u00a0E, Margolin\u00a0KA, Chow\u00a0WA, Grossmann\u00a0KF, Dietrich\u00a0E, Prieto\u00a0VG, Lowe\u00a0MC, Buchbinder\u00a0EI, Kirkwood\u00a0JM, Korde\u00a0L, Moon\u00a0J, Sharon\u00a0E, Sondak\u00a0VK, Ribas\u00a0A (2023) Neoadjuvant-adjuvant or adjuvant-only pembrolizumab in advanced melanoma. N\u00a0Engl J Med 388(9):813\u2013823. https:\/\/doi.org\/10.1056\/NEJMoa2211437","journal-title":"N Engl J Med"},{"issue":"4","key":"5511_CR29","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1001\/jamasurg.2021.7554","volume":"157","author":"ILM Reijers","year":"2022","unstructured":"Reijers\u00a0ILM, Rawson\u00a0RV, Colebatch\u00a0AJ, Rozeman\u00a0EA, Menzies\u00a0AM, van Akkooi\u00a0ACJ, Shannon\u00a0KF, Wouters\u00a0MW, Saw\u00a0RPM, van Houdt\u00a0WJ, Zuur\u00a0CL, Nieweg\u00a0OE, Ch\u2019ng\u00a0S, Klop\u00a0WMC, Spillane\u00a0AJ, Long\u00a0GV, Scolyer\u00a0RA, van de Wiel\u00a0BA, Blank\u00a0CU (2022) Representativeness of the index lymph node for total nodal basin in pathologic response assessment after neoadjuvant checkpoint inhibitor therapy in patients with stage\u00a0III melanoma. JAMA Surg 157(4):335\u2013342. https:\/\/doi.org\/10.1001\/jamasurg.2021.7554","journal-title":"JAMA Surg"},{"key":"5511_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.115141","author":"ILM Reijers","year":"2025","unstructured":"Reijers\u00a0ILM, Menzies\u00a0AM, Lopez-Yurda\u00a0M, Versluis\u00a0JM, Rozeman\u00a0EA, Saw\u00a0RPM, van Houdt\u00a0WJ, Kapiteijn\u00a0E, van der Veldt\u00a0AAM, Suijkerbuijk\u00a0KPM, Eriksson\u00a0H, Hospers\u00a0GAP, Klop\u00a0WMC, Torres Acosta\u00a0A, Grijpink-Ongering\u00a0L, Gonzalez\u00a0M, van der Wal\u00a0A, Al-Mamgani\u00a0A, Spillane\u00a0AJ, Scolyer\u00a0RA, van de Wiel\u00a0BA, van Akkooi\u00a0ACJ, Long\u00a0GV, Blank\u00a0CU (2025) Impact of personalized response-directed surgery and adjuvant therapy on survival after neoadjuvant immunotherapy in stage\u00a0III melanoma: Comparison of 3\u2011year data from PRADO and OpACIN-neo. Eur J Cancer. https:\/\/doi.org\/10.1016\/j.ejca.2024.115141","journal-title":"Eur J Cancer"},{"issue":"9","key":"5511_CR31","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1002\/(SICI)1097-0142(19960501)77:9<1809::AID-CNCR8>3.0.CO;2-6","volume":"77","author":"U Ringborg","year":"1996","unstructured":"Ringborg\u00a0U, Andersson\u00a0R, Eldh\u00a0J, Glaumann\u00a0B, Hafstr\u00f6m\u00a0L, Jacobsson\u00a0S, J\u00f6nsson\u00a0PE, Johansson\u00a0H, Krysander\u00a0L, Lagerl\u00f6f\u00a0B (1996) Resection margins of 2 versus 5\u202fcm for cutaneous malignant melanoma with a\u00a0tumor thickness of 0.8\u00a0to 2.0\u202fmm: Randomized study by the Swedish Melanoma Study Group. Cancer 77(9):1809\u20131814","journal-title":"Cancer"},{"issue":"2","key":"5511_CR32","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/s41591-020-01211-7","volume":"27","author":"EA Rozeman","year":"2021","unstructured":"Rozeman\u00a0EA, Hoefsmit\u00a0EP, Reijers\u00a0ILM, Saw\u00a0RPM, Versluis\u00a0JM, Krijgsman\u00a0O, Dimitriadis\u00a0P, Sikorska\u00a0K, van de Wiel\u00a0BA, Eriksson\u00a0H, Gonzalez\u00a0M, Torres Acosta\u00a0A, Grijpink-Ongering\u00a0LG, Shannon\u00a0K, Haanen\u00a0JBAG, Stretch\u00a0J, Ch\u2019ng\u00a0S, Nieweg\u00a0OE, Mallo\u00a0HA, Adriaansz\u00a0S, Kerkhoven\u00a0RM, Cornelissen\u00a0S, Broeks\u00a0A, Klop\u00a0WMC, Zuur\u00a0CL, van Houdt\u00a0WJ, Peeper\u00a0DS, Spillane\u00a0AJ, van Akkooi\u00a0ACJ, Scolyer\u00a0RA, Schumacher\u00a0TNM, Menzies\u00a0AM, Long\u00a0GV, Blank\u00a0CU (2021) Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage\u00a0III melanoma. Nat Med 27(2):256\u2013263. https:\/\/doi.org\/10.1038\/s41591-020-01211-7","journal-title":"Nat Med"},{"key":"5511_CR33","doi-asserted-by":"publisher","unstructured":"S3-Leitlinie zur Diagnostik, Therapie und Nachsorge des Melanoms. J\u00a0Dtsch Dermatol Ges. 2020; 18(10). German. https:\/\/doi.org\/10.1111\/ddg.14307_g","DOI":"10.1111\/ddg.14307_g"},{"issue":"6","key":"5511_CR34","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1245\/s10434-008-9888-z","volume":"15","author":"I Satzger","year":"2008","unstructured":"Satzger\u00a0I, V\u00f6lker\u00a0B, Meier\u00a0A, Kapp\u00a0A, Gutzmer\u00a0R (2008) Criteria in sentinel lymph nodes of melanoma patients that predict involvement of nonsentinel lymph nodes. Ann Surg Oncol 15(6):1723\u20131732. https:\/\/doi.org\/10.1245\/s10434-008-9888-z","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"5511_CR35","doi-asserted-by":"publisher","first-page":"e315","DOI":"10.1200\/JCO.2010.33.8210","volume":"29","author":"I Satzger","year":"2011","unstructured":"Satzger\u00a0I, Meier\u00a0A, Alter\u00a0M, Kapp\u00a0A, Gutzmer\u00a0R (2011) Which parameters to choose for prediction of non-sentinel lymph node positivity in melanoma? J\u00a0Clin Oncol 29(11):e315. https:\/\/doi.org\/10.1200\/JCO.2010.33.8210","journal-title":"J Clin Oncol"},{"key":"5511_CR36","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ejca.2019.07.004","volume":"123","author":"I Satzger","year":"2019","unstructured":"Satzger\u00a0I, Leiter\u00a0U, Gr\u00e4ger\u00a0N, Keim\u00a0U, Garbe\u00a0C, Gutzmer\u00a0R (2019) Melanoma-specific survival in patients with positive sentinel lymph nodes: Relevance of sentinel tumor burden. Eur J Cancer 123:83\u201391. https:\/\/doi.org\/10.1016\/j.ejca.2019.07.004","journal-title":"Eur J Cancer"},{"issue":"5","key":"5511_CR37","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/bjs.11168","volume":"106","author":"B Schermers","year":"2019","unstructured":"Schermers\u00a0B, Franke\u00a0V, Rozeman\u00a0EA, van de Wiel\u00a0BA, Bruining\u00a0A, Wouters\u00a0MW, van Houdt\u00a0WJ, Ten Haken\u00a0B, Muller\u00a0SH, Bierman\u00a0C, Ruers\u00a0TJM, Blank\u00a0CU, van Akkooi\u00a0ACJ (2019) Surgical removal of the index node marked using magnetic seed localization to assess response to neoadjuvant immunotherapy in patients with stage\u00a0III melanoma. Br J Surg 106(5):519\u2013522. https:\/\/doi.org\/10.1002\/bjs.11168","journal-title":"Br J Surg"},{"issue":"8","key":"5511_CR38","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1056\/NEJMoa030681","volume":"350","author":"JM Thomas","year":"2004","unstructured":"Thomas\u00a0JM, Newton-Bishop\u00a0J, A\u2019Hern\u00a0R, Coombes\u00a0G, Timmons\u00a0M, Evans\u00a0J, Cook\u00a0M, Theaker\u00a0J, Fallowfield\u00a0M, O\u2019Neill\u00a0T, Ruka\u00a0W, Bliss\u00a0JM, United Kingdom Melanoma Study Group, British Association of Plastic Surgeons, Scottish Cancer Therapy Network (2004) Excision margins in high-risk malignant melanoma. N\u00a0Engl J Med 350(8):757\u2013766. https:\/\/doi.org\/10.1056\/NEJMoa030681","journal-title":"N Engl J Med"},{"issue":"2","key":"5511_CR39","first-page":"84","volume":"32","author":"H Tritsch","year":"1981","unstructured":"Tritsch\u00a0H (1981) Die Kontinuit\u00e4tsdissektion beim malignen Melanom der Haut [Continuity dissection in malignant melanoma of the skin]. Hautarzt 32(2):84\u201390","journal-title":"Hautarzt"},{"issue":"3","key":"5511_CR40","first-page":"139","volume":"32","author":"H Tritsch","year":"1981","unstructured":"Tritsch\u00a0H (1981) Hautschnittf\u00fchrung zur Ektomie der Achsellymphknoten [Skin incision in axillary lymph node excision]. Hautarzt 32(3):139\u2013140","journal-title":"Hautarzt"},{"issue":"10197","key":"5511_CR41","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S0140-6736(19)31132-8","volume":"394","author":"D Utj\u00e9s","year":"2019","unstructured":"Utj\u00e9s\u00a0D, Malmstedt\u00a0J, Teras\u00a0J, Drzewiecki\u00a0K, Gullestad\u00a0HP, Ingvar\u00a0C, Eriksson\u00a0H, Gillgren\u00a0P (2019) 2\u2011cm versus 4\u2011cm surgical excision margins for primary cutaneous melanoma thicker than 2\u202fmm: Long-term follow-up of a\u00a0multicentre, randomised trial. Lancet 394(10197):471\u2013477. https:\/\/doi.org\/10.1016\/S0140-6736(19)31132-8","journal-title":"Lancet"},{"issue":"4","key":"5511_CR42","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1001\/archsurg.1991.01410280036004","volume":"126","author":"U Veronesi","year":"1991","unstructured":"Veronesi\u00a0U, Cascinelli\u00a0N (1991) Narrow excision (1-cm margin). A\u00a0safe procedure for thin cutaneous melanoma. Arch Surg 126(4):438\u2013441. https:\/\/doi.org\/10.1001\/archsurg.1991.01410280036004","journal-title":"Arch Surg"},{"issue":"12","key":"5511_CR43","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1056\/NEJM197709222971202","volume":"297","author":"U Veronesi","year":"1977","unstructured":"Veronesi\u00a0U, Adamus\u00a0J, Bandiera\u00a0DC, Brennhovd\u00a0IO, Caceres\u00a0E, Cascinelli\u00a0N, Claudio\u00a0F, Ikonopisov\u00a0RL, Javorskj\u00a0VV, Kirov\u00a0S, Kulakowski\u00a0A, Lacoub\u00a0J, Lejeune\u00a0F, Mechl\u00a0Z, Morabito\u00a0A, Rod\u00e9\u00a0I, Sergeev\u00a0S, van Slooten\u00a0E, Szcygiel\u00a0K, Trapeznikov\u00a0NN (1977) Inefficacy of immediate node dissection in stage\u00a01 melanoma of the limbs. N\u00a0Engl J Med 297(12):627\u2013630. https:\/\/doi.org\/10.1056\/NEJM197709222971202","journal-title":"N Engl J Med"},{"issue":"18","key":"5511_CR44","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1056\/NEJM198805053181804","volume":"318","author":"U Veronesi","year":"1988","unstructured":"Veronesi\u00a0U, Cascinelli\u00a0N, Adamus\u00a0J, Balch\u00a0C, Bandiera\u00a0D, Barchuk\u00a0A, Bufalino\u00a0R, Craig\u00a0P, De Marsillac\u00a0J, Durand\u00a0JC et\u00a0al (1988) Thin stage\u00a0I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3\u202fcm. N\u00a0Engl J Med 318(18):1159\u20131162. https:\/\/doi.org\/10.1056\/NEJM198805053181804 (Erratum in: N Engl J Med 325(4):292; PMID: 3079582)","journal-title":"N Engl J Med"},{"key":"5511_CR45","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ejca.2021.04.003","volume":"151","author":"JM Versluis","year":"2021","unstructured":"Versluis\u00a0JM, Hendriks\u00a0AM, Weppler\u00a0AM, Brown\u00a0LJ, de Joode\u00a0K, Suijkerbuijk\u00a0KPM, Zimmer\u00a0L, Kapiteijn\u00a0EW, Allayous\u00a0C, Johnson\u00a0DB, Hepner\u00a0A, Mangana\u00a0J, Bhave\u00a0P, Jansen\u00a0YJL, Trojaniello\u00a0C, Atkinson\u00a0V, Storey\u00a0L, Lorigan\u00a0P, Ascierto\u00a0PA, Neyns\u00a0B, Haydon\u00a0A, Menzies\u00a0AM, Long\u00a0GV, Lebbe\u00a0C, van der Veldt\u00a0AAM, Carlino\u00a0MS, Sandhu\u00a0S, van Tinteren\u00a0H, de Vries\u00a0EGE, Blank\u00a0CU, Jalving\u00a0M (2021) The role of local therapy in the treatment of solitary melanoma progression on immune checkpoint inhibition: A\u00a0multicentre retrospective analysis. Eur J Cancer 151:72\u201383. https:\/\/doi.org\/10.1016\/j.ejca.2021.04.003","journal-title":"Eur J Cancer"}],"container-title":["Die Dermatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-025-05511-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-025-05511-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-025-05511-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T13:44:36Z","timestamp":1748439876000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-025-05511-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,8]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["5511"],"URL":"https:\/\/doi.org\/10.1007\/s00105-025-05511-2","relation":{},"ISSN":["2731-7005","2731-7013"],"issn-type":[{"value":"2731-7005","type":"print"},{"value":"2731-7013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,8]]},"assertion":[{"value":"9 April 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.\u00a0Alter: Honorare f\u00fcr Vortr\u00e4ge und Beratung (pers\u00f6nlich): Roche Pharma, Bristol-Myers Squibb, Novartis, MSD, Almirall-Hermal, Merck-Serono, Bayer, SUN, Pierre-Fabre, Sanofi. Unterst\u00fctzung von Kongressteilnahmen (pers\u00f6nlich): SUN, Pierre-Fabre. R.\u00a0Gutzmer Forschungsunterst\u00fctzung (an Institution): Novartis, SUN, Amgen, Sanofi, Regeneron, Merck-Serono, Kyowa Kirin, Recordati, Almirall. Honorare f\u00fcr Vortr\u00e4ge und Beratung (pers\u00f6nlich): Bristol-Myers Squibb, Novartis, MSD, Almirall, Amgen, Merck-Serono, SUN, Pierre-Fabre, Sanofi, Regeneron, Immunocore, Delcath. Unterst\u00fctzung von Kongressteilnahmen (pers\u00f6nlich): SUN, Pierre-Fabre.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}